Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
about
Translating the A1C assay into estimated average glucose valuesPlace of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementGlucose control in diabetes: the impact of racial differences on monitoring and outcomesUse of metformin in diseases of agingInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesImpact of postprandial glycaemia on health and prevention of diseaseTreating the elderly diabetic patient: special considerationsIntensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapyDe novo glomerular diseases after renal transplantationClinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combinationNovel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancerRapalogs and mTOR inhibitors as anti-aging therapeuticsEffect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trialThe longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary careLearning theories reveal loss of pancreatic electrical connectivity in diabetes as an adaptive responseMultiple functional ingredient approach in formulating dietary supplement for management of diabetes: a review.Type 2 diabetes in pregnancy: exposing deceptive appearances.Clinical utility of insulin and insulin analogs.Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1,324,515 patients from observational studies.Translating clinical trial data into new patterns of practice.Standards of medical care in diabetes--2010.Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy.Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesA review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus.Protocol and baseline data from The Inala Chronic Disease Management Service evaluation study: a health services intervention study for diabetes careEffects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance.Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes.Translating the hemoglobin A1C with more easily understood feedback: a randomized controlled trial.Chinese expert consensus on bronchial asthma control.Metformin in peritoneal dialysis: a pilot experienceLiraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)Evaluation of Therapeutic Effectiveness of Prescribed Medications in Patients with Type 2 Diabetes Mellitus: Findings from a Tertiary Care Hospital, Lahore, Pakistan.Evaluation and management of diabetes mellitus.Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysisPatient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus.
P2860
Q24655833-BE783C77-338A-4269-8974-F86BD7DD3ADCQ26783199-C89101F8-BAA7-4856-B4BA-864135032FAFQ26828633-1D12E7AD-6B11-4DDB-BC5C-F3136966B815Q26828760-A3591CAD-230D-48D4-B385-5B32E1EC9050Q26861313-3762265C-E818-4B5E-81AE-80CE00753CC6Q26862823-0917E8FF-2F33-4CB7-A813-0CA41F9B942CQ26995176-AF0236F0-DE44-476E-BC01-0927BA384206Q27001931-CCF3A8BC-FA9E-43D0-8531-E75696600C5DQ27005877-FBAFD1BD-19A0-42C3-8052-C11B344D4FB4Q27026211-DE39F239-330B-4C22-B124-BCE0C74599AAQ28066348-D9EE6600-1C40-4F07-AA5A-E579145A40E3Q28286510-6CFFA0DA-246A-474B-86DD-8199E85781CDQ28473520-0D211A81-483F-4731-8C6F-61083105DBE5Q28534790-B4D162ED-AC91-4819-B1F9-E6FCC0F812D2Q28689818-35D0EC42-108B-4841-AAB3-9FF944FAEC4CQ30358713-874555F0-FD8F-4430-B8E6-14F099C8DEE2Q30367945-FADFD160-D900-45E4-A786-A012911CD114Q30429358-8CF47765-BAE7-4A37-B16E-2F9BFF89ECB3Q30438098-1D04CBB2-1AD7-4A5B-A3C0-A5E289F7C929Q30848457-C8CA40F9-88ED-411C-A85F-E7F98A793EEFQ33409374-92EE8F28-B5A8-43EA-A60D-2CDC8EA5D37CQ33554238-71306FE8-089C-4AC5-9C94-E69A8E37CD23Q33556757-2FF58C14-3C4C-499F-80BC-643AEECBCFC6Q33558371-4E496DA4-BA7B-45A1-BFE0-A1C3E398F07AQ33561396-E5F428F5-6FA6-4F30-9F0A-58EBAC96F4C6Q33584386-559BD24E-D07F-491E-832F-5C9509BFE03DQ33585555-1BE04578-A2B0-4C57-A871-66E8F223799DQ33606579-17FF6F1B-17FA-4178-BF8B-CEBD2C468D7BQ33610830-E8FD3021-6657-44E9-8071-288F4B37700DQ33751437-FE3A00B4-222C-456F-8CCC-6E4C4616DC45Q33763289-7BC3FBFC-758E-47C9-82A8-DF6A7E62E875Q33770238-2A7DC358-9182-45EB-8B5F-C1CCE17DB16AQ33814652-CFC3B689-6C69-4984-A064-AB78CE97BE87Q33837650-8D9C3E56-2DCA-426C-8AD9-F8693D4FB0CFQ33854032-D6B9331C-A65F-4CC2-9C2B-385F3A9ED9BDQ33900384-4900DBE6-EF8F-4F1B-958C-948D1B11C338Q33931988-3EE8A5A8-5368-4F19-B207-1EFB60F122A9Q33932718-35330433-E9DF-4E4B-9D9E-C3F67EF2BF40Q34016145-33C0A53F-D51A-4B7D-A59A-3C45374C80A6Q34078900-FB2017C2-1A22-4B3A-A0D3-23B64533494B
P2860
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@ast
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@en
type
label
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@ast
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@en
prefLabel
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@ast
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@en
P2093
P356
P1433
P1476
Management of hyperglycemia in ...... ion for the Study of Diabetes.
@en
P2093
David M Nathan
Mayer B Davidson
Robert J Heine
Robert Sherwin
Rury R Holman
P304
P356
10.2337/DC06-9912
P407
P577
2006-08-01T00:00:00Z